UCL Microsphere Drug Combination Patent EP4045004A1
Summary
The European Patent Office published patent application EP4045004A1 for UCL Business Ltd, titled 'Microsphere-Drug Combination.' The patent covers therapeutic compounds including microsphere formulations for drug delivery, with applications in oncology treatment (A61P 35/00). The invention involves pharmaceutical compositions using IPC classifications A61K 9/00, A61K 9/16, A61K 47/34, and related polymer and materials science classifications. The patent is designated for all European states.
What changed
The EPO published patent application EP4045004A1 for a microsphere-drug combination invented by Richard Day of UCL Business Ltd. The patent covers therapeutic formulations using microsphere technology with pharmaceutical compositions, including polymer-based drug delivery systems (IPC: A61K 9/16, A61K 47/34). The application includes oncology therapeutic claims (A61P 35/00) and is designated for all European patent convention states.
For pharmaceutical manufacturers and drug developers, this patent represents potential freedom-to-operate considerations for microsphere-based drug delivery technologies. The broad designation across European states means the patent could affect product development strategies in multiple jurisdictions if the patent grants after examination.
What to do next
- Monitor patent register for grant/opposition proceedings
- Review designated states coverage for business relevance
Archived snapshot
Apr 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
MICROSPHERE-DRUG COMBINATION
Publication EP4045004A1 Kind: A1 Apr 08, 2026
Applicants
UCL Business Ltd
Inventors
DAY, Richard
IPC Classifications
A61K 9/00 20060101AFI20260305BHEP A61K 9/16 20060101ALI20260305BHEP A61K 47/34 20170101ALI20260305BHEP A61K 47/36 20060101ALI20260305BHEP C08J 9/28 20060101ALI20260305BHEP A61L 27/56 20060101ALI20260305BHEP A61K 31/337 20060101ALI20260305BHEP A61P 35/00 20060101ALI20260305BHEP B01J 13/02 20060101ALI20260305BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.